Search Results - "Mello E Silva, Alberto"

When an affliction doesn’t come alone by Mello e Silva, Alberto

Get full text

Atherosclerosis in the primary health care setting: A real-word data study by Ascenção, Raquel, Alarcão, Joana, Araújo, Francisco, Costa, João, Fiorentino, Francesca, Gil, Victor, Gouveia, Miguel, Lourenço, Francisco, Mello e Silva, Alberto, Vaz Carneiro, António, Borges, Margarida

“…To characterize patients with atherosclerosis, a disease with a high socioeconomic impact, in the Lisbon and Tagus Valley Health Region. A cross-sectional…”
Get full text

POEMS Syndrome: an Atypical Presentation with Chronic Diarrhoea and Asthenia by Vaz, Joana Alves, Frada, Lilia, Soares, Maria Manuela, Mello E Silva, Alberto

“…POEMS syndrome is a rare paraneoplastic condition associated with polyneuropathy, organomegaly, monoclonal gammopathy, endocrine and skin changes. We report a…”
Get full text

The burden of atherosclerosis in Portugal by Costa, João, Alarcão, Joana, Araujo, Francisco, Ascenção, Raquel, Caldeira, Daniel, Fiorentino, Francesca, Gil, Victor, Gouveia, Miguel, Lourenço, Francisco, Mello e Silva, Alberto, Sampaio, Filipa, Vaz Carneiro, António, Borges, Margarida

“…Abstract Aims This article sought to estimate the burden of disease attributable to atherosclerosis in mainland Portugal in 2016. Methods and results The…”
Get full text

Management of dyslipidemia in diabetic patients: More than atheroma – The key things to understand in order to avoid a bittersweet taste by Mello e Silva, Alberto

Get full text

Current practice in identifying and treating cardiovascular risk, with a focus on residual risk associated with atherogenic dyslipidaemia by Ferrari, Roberto, Aguiar, Carlos, Alegria, Eduardo, Bonadonna, Riccardo C, Cosentino, Francesco, Elisaf, Moses, Farnier, Michel, Ferrières, Jean, Filardi, Pasquale Perrone, Hancu, Nicolae, Kayikcioglu, Meral, Mello E Silva, Alberto, Millan, Jesus, Reiner, Željko, Tokgozoglu, Lale, Valensi, Paul, Viigimaa, Margus, Vrablik, Michal, Zambon, Alberto, Zamorano, José Luis, Catapano, Alberico L

“…A panel of European experts on lipids and cardiovascular disease discussed clinical approaches to managing cardiovascular risk in clinical practice, including…”
Get full text

Whipple’s disease: a rare case of malabsorption by Lopes, Ana, Santos, Ana Filipa, Alvarenga, Maria Joana, Mello e Silva, Alberto

“…Whipple’s disease is a chronic, rare, multisystemic, infectious entity, described for the first time in 1907. Its aetiological agent is the Gram-negative rod,…”
Get full text

Statin-associated muscle symptoms: position paper from the Luso-Latin American Consortium by Sposito, Andrei C., Faria Neto, José Rocha, Carvalho, Luiz Sergio F. de, Lorenzatti, Alberto, Cafferata, Alberto, Elikir, Gerardo, Esteban, Eduardo, Morales Villegas, Enrique C., Bodanese, Luiz Carlos, Alonso, Rodrigo, Ruiz, Alvaro J., Rocha, Viviane Z., Faludi, André A., Xavier, Hermes T., Coelho, Otávio Rizzi, Assad, Marcelo H.V., Izar, Maria C., Santos, Raul D., Fonseca, Francisco A.H., Mello e Silva, Alberto, Silva, Pedro Marques da, Bertolami, Marcelo C.

“…In the last two decades, statin therapy has proved to be the most potent isolated therapy for attenuation of cardiovascular risk. Its frequent use has been…”
Get full text

Yellow Nail Syndrome: Report of Two Cases and a Brief Review of the Current Literature by Oliveira, Eunice, Santos, Sofia Marques, Monteiro, Nuno Ferreira, Soares, Maria Manuela, Mello E Silva, Alberto

“…Yellow Nail Syndrome (YNS) is a rare, and probably misdiagnosed, condition. It must be considered in middle-aged patients with unexplained chronic respiratory…”
Get full text

Large Morgagni Hernia in an Adult Patient by Santos, Sofia Marques, Oliveira, Eunice, Monteiro, Nuno Ferreira, Soares, Maria Manuela, Mello E Silva, Alberto

“…A 70-year-old woman presented to the emergency department with symptoms of a lower respiratory infection. A chest x-ray showed enlargement of the mediastinal…”
Get full text

Heaven can wait… for lipid control in very high cardiovascular risk patients by Mello e Silva, Alberto

Get full text

Practical guidance for combination lipid-modifying therapy in high- and very-high-risk patients: A statement from a European Atherosclerosis Society Task Force by Averna, Maurizio, Banach, Maciej, Bruckert, Eric, Drexel, Heinz, Farnier, Michel, Gaita, Dan, Magni, Paolo, März, Winfried, Masana, Luis, Mello e Silva, Alberto, Reiner, Zeljko, Ros, Emilio, Vrablik, Michal, Zambon, Alberto, Zamorano, Jose L., Stock, Jane K., Tokgözoğlu, Lale S., Catapano, Alberico L.

“…This European Atherosclerosis Society (EAS) Task Force provides practical guidance for combination therapy for elevated low-density lipoprotein cholesterol…”
Get full text

When an affliction doesn't come alone by Mello E Silva, Alberto

Get full text

Evaluation of lipoprotein(a) in the prevention and management of atherosclerotic cardiovascular disease: A survey among the Lipid Clinics Network by Catapano, Alberico L., Tokgözoğlu, Lale, Banach, Maciej, Gazzotti, Marta, Olmastroni, Elena, Casula, Manuela, Ray, Kausik K.

“…The European Atherosclerosis Society (EAS) Lipid Clinics Network promoted a survey in order to identify and understand how and when lipoprotein(a) [Lp(a)] is…”
Get full text

Atherogenic markers in predicting cardiovascular risk and targeting residual cardiovascular risk by Catapano, Alberico L., Tokgözoğlu, Lale, Mello e Silva, Alberto, Bruckert, Eric

“…Low-density lipoprotein (LDL) cholesterol (LDL-C) is the primary target in cardiovascular (CV) disease prevention and is commonly used in estimating CV risk;…”
Get full text

Pharmaceutical strategies for reducing LDL-C and risk of cardiovascular disease by Catapano, Alberico L., Tokgözoğlu, Lale, Mello e Silva, Alberto, Bruckert, Eric

“…A key strategy in preventing cardiovascular (CV) disease is the reduction of low-density lipoprotein cholesterol (LDL-C). Statins are a crucial therapy for…”
Get full text

The burden of cholesterol accumulation through the lifespan: why pharmacological intervention should start earlier to go further? by Zambon, Alberto, Mello e Silva, Alberto, Farnier, Michel

“…Abstract Among the cardiovascular risk factors, cholesterol-rich atherogenic lipoproteins play a central role in the pathogenesis of atherosclerosis. In…”
Get full text

CODAP: um consenso multidisciplinar sobre a definição, diagnóstico e tratamento da dislipidemia aterogénica em Portugal by Alberto Mello e Silva, Carlos Aguiar, João Sequeira Duarte, Luciana Couto, Manuel Teixeira Veríssimo, Pedro Marques da Silva

“…Resumo: Introdução e objetivos: A dislipidemia aterogénica contribui consideravelmente para o risco residual de doença cardiovascular (DCV); não obstante,…”
Get full text

CODAP: A multidisciplinary consensus among Portuguese experts on the definition, detection and management of atherogenic dyslipidemia by Mello E Silva, Alberto, Aguiar, Carlos, Sequeira Duarte, João, Couto, Luciana, Teixeira Veríssimo, Manuel, Marques da Silva, Pedro

“…Atherogenic dyslipidemia is an important contributor to residual cardiovascular (CV) risk, but it is underdiagnosed and undertreated. This study aimed to…”
Get full text

Os custos da aterosclerose em Portugal by João Costa, Joana Alarcão, Alexandre Amaral‐Silva, Francisco Araújo, Raquel Ascenção, Daniel Caldeira, Marta Ferreira Cardoso, Manuel Correia, Francesca Fiorentino, Cristina Gavina, Victor Gil, Miguel Gouveia, Francisco Lourenço, Alberto Mello e Silva, Luís Mendes Pedro, João Morais, António Vaz‐Carneiro, Manuel Teixeira Veríssimo, Margarida Borges

“…Resumo: Introdução e objetivos: As doenças cardiovasculares são a principal causa de morte em Portugal, sendo a aterosclerose o processo fisiopatológico…”
Get full text